ENTITY GenSci155

GenSci155

PulseAugur coverage of GenSci155 — every cluster mentioning GenSci155 across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

TOPICS

TIMELINE

2026-07-24 product_launch Changchun High-Tech's subsidiary, Gensci Pharmaceutical, received acceptance for its clinical trial application for the GenSci155 injection. source

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

TOOL · CL_161441 · Jul 24 · 10:44

长春高新 subsidiary's drug trial accepted; Rongda Guanggu plans fundraising

Changchun High-Tech's subsidiary, Gensci Pharmaceutical, has received acceptance for its clinical trial application for the domestic production of the GenSci155 injection. This drug is intended for the prevention of bro…